The use of antibiotic-resistance markers for the selection of recombinant mycobacteria is widespread but questionable considering the development of live recombinant BCG vaccines. In contrast, vector-encoded resistance to heavy metals such as mercury may represent an interesting alternative for the development of live vaccines compatible with use in humans and in animals. The mercury resistance genes (mer) from Pseudomonas aemginosa and from Serratia marcescens were cloned into the Escherichia coli-Mycobacterium shuttle vector pRR3. The resulting vectors, designated pMROOl and pVN2, were introduced by elect ro pora t ion in to Mycobacterium smegma tis, Mycobacterium bowis BCG and Mycobacterium tuberculosis. The recombinant mycobacteria were stable in witro and in wiwo, and had high-level mercury resistance, thus indicating that the mer genes can be useful as selective markers in mycobacteria.
INTRODUCTION
The genus Mycobacteritlm encompasses more than 50 species including major human pathogens, such as Mycobacteritlm ttlberctllosis and Mycobacteritlm leprae. Mycobacterial infections, especially tuberculosis, remain among the world's leading causes of death, mainly in the developing world. In addition, with the appearance and spread of AIDS, tuberculosis as well as opportunistic mycobacterial infections have re-emerged as serious threats in the United States and in Europe. The recent appearance of multidrug-resistant strains is of especially great concern for public health (Bloom & Murray, 1992) .
Despite the fact that M. ttlberculosis was one of the first micro-organisms to be recognized as a human pathogen, its molecular genetics remains poorly understood. This may in part be related to the slow growth rate of these organisms, the difficulty of introducing foreign DNA, and the lack of suitable cloning vectors. However, the development of efficient electroporation methods (Snapper e t al., l988), and the construction of autonomously replicating shuttle vectors (Ranes et al., 1990), have, in In addition, several important breakthroughs have led to the promising utilization of attenuated mycobacteria as multiple live-vaccine carriers (Stover e t al., 1991) . Mycobacterizlm bovis bacille Calmette-Gukrin (BCG) has been used for several decades as a live vaccine against tuberculosis, with a remarkably low record of serious side effects (WHO, 1991) . Recently developed molecular tools have opened the possibility of introducing and expressing genes coding for foreign antigens in BCG vaccine strains, and of constructing recombinant multivalent BCG strains capable of immunizing and protecting against multiple infectious diseases simultaneously (Stover et al. , 1993) .
The cloning vectors currently most widely used in mycobacteria are shuttle plasmids based on pAL5000 isolated from Mycobacterium fortuittlm (Labidi e t al., 1985) , although others, such as pMSC262-derivatives isolated from Mycobacterium scrofulacetlm (Goto e t al., 1991) , and even RSFlOlO and its derivatives (Gormley & Davies, 1991; A. Baulard and others, unpublished) can also be used. Mycobacteria are generally resistant to many antibiotics, probably due to their inherently complex cell wall, and therefore transformed mycobacteria can be selected only by resistance to a limited panel of antibiotics. Thus far, most investigators have used the aph gene which 0001-9558 0 1995 SGM (1990) confers high-level resistance to kanamycin in BCG (Murray et al., 1992; Stover e t al., 1991 Stover e t al., , 1993 Tuovinen, 1984) .
Mercury resistance is usually determined by plasmids or transposons that contain up to six mer genes; these genes are involved in mercury uptake, resistance or regulation, and are organized in operons (for a review see Misra, 1992) . The key enzyme is the merA-encoded mercuric reductase, which reduces Hg2+ to Hg', a highly volatile compound easily eliminated by the bacterium. Sometimes the operons contain an additional gene, merB, encoding an organomercurial lyase, an enzyme capable of cleaving C-Hg bonds to yield Hg2+, which is subsequently reduced by the merA gene product. Other mer genes are involved in transport or genetic regulation of the operon.
Meissner & Falkinham (1 984) showed that mycobacteria are generally sensitive to mercury and that resistance of some strains is related to the presence of a megaplasmid probably containing mercury-resistance genes. In this study we investigated the possibility of using mer genes from P. aertlginosa and Serratia marcemnx for the construction of useful cloning vectors providing selectable resistance to organic and inorganic mercury in recombinant mycobacteria.
METHODS
Plasmids, bacterial strains and culture conditions. The plasmids, as well as the Escherichia coli and mycobacterial strains used in this study, are listed in Table 1 . The E. coli strains were grown in LB medium as described by Sambrook et al. ( 1 989 (Sauton, 1912) was used for growth ofthe mycobacteria in liquid medium.
Genetic constructions.
All genetic constructions and plasmid analyses were carried out using standard procedures as described by Sambrook et a/. (1989) . Electrotransformation of mycobacteria using the Cell Ject apparatus (Eurogentec) and analysis of plasmids by electroduction was performed as described previously (Baulard e t a/. , 1992).
Estimation of mercury MICs. T o estimate the MIC, which was defined as the lowest concentration of the mercury compounds at which no bacterial growth was detected, 10 pl mycobacterial suspensions (1 08-109 bacteria ml-l) were spotted onto Middlebrook 7H10 agar, or 100 pl of the suspension was inoculated in Roux bottles containing 10 ml liquid medium each supplemented with increasing concentrations of HgC1, or PMA. The cultures were incubated at 37 "C for 5 d (for M . smegmatis) or 2-3 weeks (for BCG and M. tuberculosis) until bacterial growth was detected in the controls. Mercury resistance in mycobacteria without 10 mg PMA 1-1 for BCG(pVN2) or 12 mg HgC1, 1-1 for BCG(pMR001) ; plates were then incubated for 2 weeks at 37 OC.
RESULTS

Construction of mycobacterial shuttle vectors
containing the mer operons of P. aeruginosa and S.
marcescens
The mer operons from plasmids pHP451nHg (from P. aergginosa) and pLOFHg (from S. marcescens) were introduced separately into the E. coli-mycobacterial shuttle vector pRR3 using the following cloning strategies. The 4.3 kb SmaI fragment of pHP451nHg, containing the complete Tn501 mer operon, was inserted into the unique Sea1 site of pRR3. After ligation and transformation of E. coli XL1-Blue, the transformants were plated onto LB agar supplemented with 12 mg HgC1, 1-l. Mercuryresistant colonies appeared after overnight incubation at 37 OC, whereas no mercury-resistant colonies developed on LB agar + HgCl, plated with E. coli XL1-Blue(pRR3).
The plasmids from 10 mercury-resistant clones were extracted and analysed, confirming the presence of recombinant plasmids with the expected restriction pattern (data not shown). One of these plasmids, designated pMROOl ( Fig. la) , was then purified by the alkaline-lysis method.
To clone the mer operon from S. marcescens into pRR3, a 3 kb M l d fragment was isolated from pLOFHg, bluntended using DNA polymerase I (Klenow fragment) and then inserted into the unique ScaI site of pRR3. The recombinant plasmids were introduced into E. coli XL1-Blue and the transformants selected on LB agar supplemented with 10 mg PMA 1-l. After isolation and restriction analysis of the recombinant plasmids, one representative showing the correct restriction pattern was purified and designated pVN2 (Fig. lb) .
Mycobacterial resistance to inorganic mercury in liquid medium
M. smegmatis mc2155, M. bovis BCG 1173P2 and M.
ttlbercdosis H37Ra were transformed with pMROOl and pVN2. Since both plasmids contain the aph gene in addition to their mer genes, the transformants were first selected on Middlebrook 7H10 agar supplemented with
Middlebrook ADC Enrichment and 20 mg kanamycin 1-l. After incubation at 37 OC for 5 d (for M . smegmatis) or 2-3 weeks (for BCG or M . tzlbercdosis), single kanamycinresistant colonies were obtained for all three mycobacteria. To ensure that the kanamycin resistance was due to the presence of pMR001 or pVN2, four isolated colonies for each species and for each plasmid were analysed by electroduction. All plasmids isolated from the mercury-resistant E. coli back-transformants displayed the correct restriction pattern (data not shown). The recombinant mycobacteria were then transferred to mercurycontaining growth medium to assess whether mercuryresistance could be expressed in mycobacteria using the mer genes from P. aerzlginosa or S. marcescens. $ Phenotype on Middlebrook 7H10 agar supplemented with 12 mg HgC1, 1-1 or 10 mg PMA 1-l; S, sensitive; R, resistant.
As shown in Table 2 , untransformed mycobacteria or organisms transformed with pRR3 were highly susceptible to mercury. As little as 0-15 mg 1-' HgCl, or PMA in solid medium, and 1.25 mg 1-1 or 0.15 mg 1-' HgC1, or PM A, respectively, in liquid medium, totally inhibited growth. In contrast, growth of pMROOl -containing mycobacteria was only inhibited above 160 mg HgCl, 1-' on solid medium or 40 mg HgC1, 1-' in liquid medium, whereas they were susceptible to PMA in both media, which was expected. The pVN2-harbouring mycobacteria were found to be as resistant as the pMROOl-containing bacteria to HgCl,, but, in addition, showed increased levels of resistance to PMA, with MIC values of 40 mg 1-'and 5 mg 1-' for solid and liquid medium, respectively. Interestingly, similar results were obtained for each plasmid, regardless of which of the three mycobacterial species was analysed.
Plasmid stability in BCG
The stability of plasmids was analysed by infecting mice with BCG(pMR/001) or BCG(pVN2) and, after 2 weeks, plating serial dilutions of their homogenized spleens onto Middlebrook 7H10 agar with or without 10 mg PMA 1-' for BCG(pVN2) or 12 mg HgC1, 1-' for BCG(pMR001).
After 2 weeks' growth at 37 "C, all plates contained about the same number of viable colonies (105-106 per spleen) regardless of the presence or absence of the mercuric compounds, indicating that pMROOl and pVN2 are both highly stable in vivo in the absence of selective pressure.
Direct use of mercury resistance for the selection of recombinant mycobacteria
To investigate whether mercury resistance encoded by pMROOl or pVN2 can be directly used for the selection of transformed mycobacteria, each plasmid was electroporated into all three bacterial species and the transformants were directly plated onto Middlebrook 7H10 agar supplemented with 12 mg HgC1, 1-' or 10 mg PMA 1-' . After 5 d (for M. smegmatis) or 2 to 3 weeks (for BCG or M. tzlberczrlosis) of growth at 37 OC, lo3 HgC1,-resistant colonies (pg plasmid DNA)-' were obtained for each species and lo3 PMA-resistant colonies (pg pVN2 DNA)-' were obtained. No growth was observed for either species transformed with pRR3. In all cases, backtransformation to E. coli by electroduction confirmed the presence of the expected plasmids in the resistant mycobacterial colonies. Interestingly, the numbers of mercuryresistant clones were generally 2-5-fold higher than the number of kanamycin-resistant clones after transformation with the same plasmids, suggesting that mycobacteria tolerate selection on mercury better than selection on kanamycin.
DISCUSSION
The insertion of the mer operons from Tn501 or from pDUl358 into pAL5000-derivatives resulted in the construction of stable recombinant plasmids which supported the growth of mycobacteria in mercury-supplemented media. These results demonstrate that the mer genes from P. aerzlginosa or S. marcescens are expressed in recombinant mycobacteria and provide useful selectable markers. The introduction of pMROOl or pVN2 in mycobacteria induces high-levels of mercury resistance, with MIC values 40-1 00-fold greater than background values for HgC1, and 20-100-fold for PMA. The MIC values were always lower in liquid medium as opposed to solid medium, most likely because of better exposure of the bacteria to mercurial compounds in liquid medium. Similar levels of resistance were observed with all three mycobacteria tested, suggesting that the copy number of the vectors, as well as the expression levels of the mer genes, are similar in the three organisms, regardless of differences in growth rate. Besides safety considerations, the mer genes studied here offer certain advantages over the most commonly used E. coli-derived aminoglycoside phosphotransferase gene, in that selection on mercury compounds gave consistently higher transformation frequencies than selection on kanamycin. A similar observation has also recently been reported when a hygromycin-resistance marker was compared to the kanamycinresistance marker (Garbe e t al., 1774) . As reported for the use of hygromycin-resistance, selection by mercuryresistance may therefore also be helpful for the transformation of mycobacteria that have so far been refractory to transformation, especially those that are already resistant to the commonly used antibiotics.
Given that the spectra of resistance of the transformed bacteria correspond to that of the introduced respective mer operons (see Table 2 ), at least the merA gene of pMROOl and both the merA and merB genes of pVN2 are expressed. In addition, both the mercuric reductase and the organomercurial lyase encoded by these genes are enzymatically active within the mycobacterial cell.
Whether the other genes of the mer operons, merT, merP and merD, are also expressed is unknown at present.
Mercury resistance in mycobacteria
However, it is likely that at least the merT and merP genes of both mer operons are also transcribed, because they constitute the first two cistrons in the polycistronic mer operons. Even if these genes are transcribed, it is possible that their products are not needed for mercury resistance in mycobacteria, because, unlike for Gram-negative bacteria, transport proteins are not required for mercurial resistance in Gram-positive bacteria (Silver & Laddaga, 1990) .
The mer operons are most likely expressed under the control of their own promoter sequences in the mycobacteria, because similar levels of resistance are obtained regardless of the orientation of the mer operons in the pRR3 derivative (compare the orientation of the mer genes in pMROOl with that in pVN2; see Fig. 1 ). Although the two mer operons come from different bacteria, the operator-promoter sequences are almost identical (Griffin e t al., 1987; Misra e t al., 1984) . In addition, deletion of vector DNA upstream of the mer operon, up to the NdeI site of pVN2 shown in Fig. l(b coli induction of the mer operon by MerR increases expression about 100-fold (Ross et al., 1989) . Therefore, one might expect drastically increased mer promoter activity in pMROOl compared to pVN2, if high levels of functional MerR were produced in mycobacteria transformed with pMR001; this was not seen in this study.
Concluding remarks
Whatever the mechanism of expression of mercury resistance might be in mycobacteria, the pRR3-derivatives constructed in this study showed high stability both in vitro after several subcultures in the absence of selective pressure (A. Baulard, unpublished observations) and in vivo in the spleen of intravenously infected mice. Their high stability, combined with mercury-resistance markers, is safe for the environment, and in the absence of antibiotic-resistance markers make such vectors ideal tools for the production of heterologous antigens in BCG with the aim of developing new recombinant live vaccines for human and animal use. In addition, recombinant mycobacteria resistant to mercury rather than to antibiotics should facilitate safe molecular approaches for the study of pathogenesis in a wide array of animal models. The use of mercury resistance is, in principle, not limited to the selection of mycobacteria containing recombinant plasmids, but should also prove useful for the selection of chromosomal integration events through transposition, phage integration or recombination. Because of the relatively small quantities of mercury compounds used in laboratory-scale experiments, the release of Hgo from the recombinant mycobacteria is generally insignificant. The inherent plasmid stability in mycobacteria decreases the need for continued addition of mercury compounds in preparative-scale cultures. If the presence of those compounds in large-scale fermenters is nevertheless required, proper ventilation should prevent the accumulation of toxic mercury vapours.
